FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
PAR PHARMACEUTICAL COMPANIES, INC. [ PRX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 01/06/2011 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) 01/10/2011 |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock(1) | 01/06/2011 | A | 50,629 | A | $0 | 271,812 | D | |||
Common Stock(2) | 01/10/2011 | F | 6,982 | D | $36 | 265,817(3) | D | |||
Common Stock | 15,000 | I | By Limited Partnershp(4) | |||||||
Common Stock | 15,000 | I | By Trust(5) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Award of shares of Restricted Stock under the Company's 2004 Performance Equity Plan, which vest on the earlier of (a) December 31, 2013, (b) the date that a Change of Control occurs and (c) the date of an eligible termination of the Employment Term (subject to the terms as set forth in the Reporting Person's Employment Agreement and the 2011 Award Agreement). The closing price of the Company's Common Stock as reported by The New York Stock Exchange on the date of grant was $36.54. This Amendment to the Form 4 filed on 1/10/2011 is being filed to correct the errors in the (i) amount of the award of shares of Restricted Stock, and (ii) the vesting terms of such award. |
2. Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock approved in accordance with Rule 16b-3. This Amendment to the Form 4 filed on 1/12/2011 is being filed to correct the number of shares surrendered in payment of tax withholding due as a result of the vesting of Restricted. |
3. Includes (i) 103,582 shares of Common Stock, and (ii) 159,735 shares of Restricted Stock and Restricted Stock Units, held by Mr. LePore. This Amendment to the Forms 4 filed on 1/10/2011 and 1/12/2011 is being filed to correct the number of securities beneficially owned following the reported transactions. |
4. The shares are held by Park Street Investors, L.P. ("PSI"), a Delaware limited partnership. The General Partner of PSI is Park Street Investment Corporation ("PSIC"), a Delaware corporation, of which Mr. LePore and his spouse are officers and directors and together own a majority of the outstanding stock of PSIC. |
5. The shares are held by the Patrick LePore Revocable Trust of 2002, of which Mr. LePore is the Grantor, Trustee and beneficiary. |
/s/ Marian E. Gustafson for Patrick G. LePore | 01/31/2011 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |